Revolution Medicines, Inc. (RVMD)
190.86
-3.09
(-1.59%)
USD |
NASDAQ |
Oct 13, 11:43
Revolution Medicines Free Cash Flow : -1.232B for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.232B |
| March 31, 2026 | -1.072B |
| December 31, 2025 | -913.73M |
| September 30, 2025 | -777.08M |
| June 30, 2025 | -700.36M |
| March 31, 2025 | -601.72M |
| December 31, 2024 | -567.74M |
| September 30, 2024 | -551.11M |
| June 30, 2024 | -520.20M |
| March 31, 2024 | -457.88M |
| December 31, 2023 | -358.30M |
| September 30, 2023 | -300.08M |
| Date | Value |
|---|---|
| June 30, 2023 | -252.32M |
| March 31, 2023 | -242.32M |
| December 31, 2022 | -235.22M |
| September 30, 2022 | -211.00M |
| June 30, 2022 | -192.78M |
| March 31, 2022 | -169.93M |
| December 31, 2021 | -153.71M |
| September 30, 2021 | -139.46M |
| June 30, 2021 | -130.13M |
| March 31, 2021 | -115.20M |
| December 31, 2020 | -103.00M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Moderna, Inc. | -1.244B |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Intellia Therapeutics, Inc. | -348.69M |
| Twist Bioscience Corp. | -93.22M |
| Beam Therapeutics, Inc. | -372.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -387.32M |
| Cash from Investing (Quarterly) | -1.659B |
| Cash from Financing (Quarterly) | 2.420B |
| Free Cash Flow Per Share (Quarterly) | -1.847 |
| Free Cash Flow to Equity (Quarterly) | -1.143B |
| Free Cash Flow to Firm (Quarterly) | -365.82M |
| Free Cash Flow Yield | -3.25% |